Therefore, the elevation of KLF4 mRNA expression levels may lead to an increased risk of HT in the study populations, and antihypertensive drugs may reduce the expression levels of KLF4, thereby lowering blood pressure to a certain extent. The gene discussed is KLF4; the disease is hematocrit.